JAK inhibitor and use thereof

US11427581B2 · kind B2 · utility

Assignee

• ZHUHAI UNITED LABORATORIES CO., LTD. · CN

Inventors

• Weiwei MAO · 安丰镇, CN
• Hao Wu · Shanghai, CN
• Xuejian Zheng · Shanghai, CN
• Guoping HU · Shanghai, CN
• Changqing Wei · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Jan 31, 2019
• Grant date: Aug 30, 2022
• Expiry date: Jun 18, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D513/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed in the present application are a class of compounds as JAK inhibitors and use thereof in the preparation of medicaments for treating JAK and TYK2 related diseases. Specifically, a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof is disclosed.